John Greene - Director at CRISPR Therapeutics AG

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
CRSP on Nasdaq
All Insider Reports
All Insider Reports

John Greene - trading volume in the past year for CRISPR Therapeutics AG

Holdings reported by John Greene for CRISPR Therapeutics AG

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Shares 7,000 $313,948 $44.85 26 Feb 2025 Direct
Stock Option (Right to Buy) 13,000 05 Jun 2025 Direct Common Shares

Transactions reported by John Greene for CRISPR Therapeutics AG

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.